Explore / Peer-reviewed article
Peer-reviewed article

Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.

Berg CJ, LoParco CRiD, Rossheim MEiD, McCready DM, Langan L, Platt E, Romm KF, Johnson M, Speer MB, Burris SiD, Cavazos-Rehg PA

Drug and alcohol dependenceMay 26, 2026United States0 citationsDOI: 10.1016/j.drugalcdep.2026.113218

Abstract

<h4>Objective</h4>This study used mystery shoppers to assess cannabis retail practices in 5 US states regulating legal nonmedical cannabis retail.<h4>Methods</h4>This mystery shopper study assessed 130 cannabis retailers in 5 cities (Los Angeles [LA], California; Las Vegas [LV], Nevada; Denver, Colorado; Portland, Oregon; Seattle, Washington) in summer 2025. Researchers recorded: 1) age verification; and 2) retail staff responses to inquiries about: a) use for anxiety, sleep, pregnancy-related nausea, etc.; b) use-related risks/cautions; c) interstate cannabis transport; and d) availability of derived intoxicating cannabis products (DICPs) and 'mushrooms' (psilocybin).<h4>Results</h4>Mystery shoppers were asked for ID at 87.7% of retailers. When asked, most (>88%) retail staff responded that cannabis helps with anxiety and insomnia. While 40.8% warned against use for pregnancy-related nausea, 36.2% suggested it helps and 24.6% said it depends on the person/situation. Over half (58.5%) warned against driving post-use, but 50.0% said it depends (on person/situation). When asked about interstate transport, several indicated not to (42.3%) and/or it was illegal (39.2%); however, 44.6% indicated ways to pack cannabis to be undetectable, and 27.7% said not to worry about getting caught. Retail staff generally indicated DICPs are not as safe as delta-9 THC (27.7%) or are illegal (20.0%). The majority said mushrooms were illegal (67.7%), but 53.8% indicated they were easy to obtain, and 29.2% suggested their mental health benefits.<h4>Conclusions</h4>Cannabis retailer frequently made prohibited health claims and minimized risks, reinforcing public health concerns and the need for ongoing cannabis retail surveillance and stronger regulatory oversight and enforcement.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAnxiety

Keywords

MarketingDrug UseHealth CommunicationCannabis PolicyMarijuana DispensariesΔ9-thc (Delta-9 Tetrahydrocannabinol)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.